Related Experiment Video
Updated: Feb 2, 2026
Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
Published on: February 22, 2019
Posttransplant Malignancy
Ana P Rossi1, Christina L Klein2
1Maine Medical Center, Maine Transplant Program, 19 West Street, Portland, ME 04102, USA.
Abstract:
Posttransplant malignancy is a leading cause of death after solid organ transplantation (SOT). Recipients of SOT are at significantly higher risk of multiple cancers compared with the general population, most notably nonmelanoma skin cancer and posttransplant lymphoproliferative disorders. Risk factors for posttransplant malignancy include history of malignancy, immunosuppression, oncogenic viral infections, sun exposure, and disease-specific associations. Early detection and treatment of malignancies can improve survival.
